NASD Clearance. By the Effective Date, the Representative shall have received clearance from the NASD as to the amount of compensation allowable or payable to the Underwriters as described in the Registration Statement.
NASD Clearance. By the Effective Date, the Underwriter shall have received clearance from the NASD as to the amount of compensation allowable or payable to the Underwriter as described in the Registration Statement.
NASD Clearance. 18 4.1.3 No Blue Sky Stop Orders...............................................................18 4.2
NASD Clearance. By the Effective Dxxx, xhe Representative shall have received clearance from the NASD as to the amount of compensation allowable or payable to the Underwriters as described in the Registration Statement.
NASD Clearance. The NASD shall not have raised any objection with respect to the fairness or reasonableness of the underwriting or other arrangements of the transactions contemplated hereby.
NASD Clearance. By the Xxxxxxxxe Date, the Co-Representatives shall have received clearance from the NASD as to the amount of compensation allowable or payable to the Underwriters as described in the Registration Statement.
NASD Clearance. 17 4.1.3 NO BLUE SKY STOP ORDERS. . . . . . . . . . . . . . . . . . .17 4.2
NASD Clearance. By the Effective Dxxx, xxe Underwriter shall have received clearance from the NASD as to the amount of compensation allowable or payable to the Underwriter as described in the Registration Statement.
NASD Clearance. By the Effective Date, (i) the Representative shall have received clearance from the NASD as to the amount of compensation allowable or payable to the Underwriters as described in the Registration Statement; and (ii) Cardinal Capital Management, Inc. shall have been approved as a qualified independent underwriter for this offering.
NASD Clearance. The Placement Agent shall have received clearance from the National Association of Securities Dealers, Xxx.xx to the amount of compensation allowable or payable to the Placement Agent as described in the SB-2.